Skip to main content
CHAM logo

Champion Investments, Inc. (CHAM) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0002 $0.00 (0.00%)
P/E Ratio: 0.29| Vol: 300| 52-wk range: $0.0001 – $0.0002

P/E 0.29 means the share price is 0.29 times one year of earnings per share.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Champion Investments, Inc. (CHAM) trades at $0.0002. Champion Investments, Inc. is a private equity and venture capital firm based in Houston, Texas, specializing in early-stage to middle-market companies across technology, life sciences, medical, and consumer sectors. Sector: Financials.

Price as of · Last analyzed: Jun 15, 2026
Champion Investments, Inc. is a private equity and venture capital firm based in Houston, Texas, specializing in early-stage to middle-market companies across technology, life sciences, medical, and consumer sectors. The firm focuses on U.S. investments, targeting companies with specific revenue and EBITDA ranges for a three to seven-year return horizon.

Analyst Coverage for CHAM: CHAM does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the CHAM film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Champion Investments, Inc. (CHAM) Financial Services Profile

CEOKerri G. Schomette
Employees3
HeadquartersHouston, US
IPO Year2007

Champion Investments, Inc. is a Houston-based private equity and venture capital firm specializing in early-stage to middle-market U.S. companies within technology, life sciences, medical, and consumer sectors. The firm targets specific revenue and EBITDA profiles, aiming for investment returns over a three to seven-year timeframe through various investment strategies.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 15, 2026

What Is the Investment Thesis for CHAM?

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

Champion Investments, Inc. operates with a focused private equity and venture capital strategy, targeting U.S.-based companies in technology, life sciences, medical, and consumer sectors with revenues between $2 million and $25 million and EBITDA between 10-30%. The firm's reported profit margin of 6203.4% and gross margin of 100.0% suggest highly efficient operations or significant gains from its investment portfolio, although its market capitalization is reported as $0.00B, indicating a very small or illiquid public presence. The P/E ratio of 0.29 further highlights a potentially undervalued or highly profitable entity relative to its earnings. The firm's investment horizon of three to seven years for returns aligns with typical private equity strategies, focusing on long-term value creation through early-stage, growth, and recapitalization investments. The reported beta of -130.35 is an extreme outlier, suggesting a highly inverse correlation to market movements, which could be a characteristic of its specific investment holdings or an anomaly given its OTC status and small scale. Growth catalysts are tied to successful exits from its portfolio companies and the ability to identify and invest in promising ventures within its target sectors, leveraging its specialized criteria to generate substantial returns.

Based on FMP financials and quantitative analysis

CHAM Key Highlights

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

Champion Investments, Inc. reports an exceptional Profit Margin of 6203.4%, indicating highly profitable operations relative to its revenue.

  • The firm maintains a perfect Gross Margin of 100.0%, suggesting either no cost of goods sold or that its revenue is entirely profit-generating from its investment activities.
  • Champion Investments, Inc. trades at a P/E ratio of 0.29, which is significantly low and could imply strong earnings relative to its market valuation, or a very small market capitalization.
  • The company's market capitalization is reported as $0.00B, highlighting its status as a micro-cap or extremely illiquid entity on the OTC market.
  • A reported Beta of -130.35 is an extreme statistical outlier, suggesting a highly inverse correlation to the broader market, which is unusual for a financial services firm and may reflect its unique private investment portfolio dynamics or limited public trading activity.

Who Are CHAM's Competitors?

CHAM is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
BTTC Black Titan Corporation $0.68 +4.85% $5.12M 54 5-pillar
FOFO Hang Feng Technology Innovation Co., Ltd. $2.08 -0.48% $15.8M 79 5-pillar
BCG Binah Capital Group, Inc. $1.05 +3.96% $17.0M 79 5-pillar
PDPA Pearl Diver Credit Company Inc. $24.87 -0.36% $59.0M 52 5-pillar
SSEA Starry Sea Acquisition Corp $10.38 +0.05% $79.2M 54 5-pillar
SAMG Silvercrest Asset Management Group Inc. $10.62 +0.76% $81.0M 50 5-pillar
HNNA Hennessy Advisors, Inc. $10.41 +0.97% $81.5M 85 5-pillar
ALIS Calisa Acquisition Corp $10.31 -0.19% $87.1M 65 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CHAM's Key Strengths?

Highly specialized investment focus across technology, life sciences, medical, and consumer sectors.

  • Clear investment criteria for target companies (revenues $2-$25M, EBITDA 10-30%), enabling disciplined deal selection.
  • Diverse investment strategies including early-stage, growth, acquisitions, and recapitalizations.
  • Exceptional reported profit margin (6203.4%) and gross margin (100.0%) indicating strong financial performance from investments.
  • Lean operational structure with 3 employees, potentially leading to efficient decision-making.

What Are CHAM's Weaknesses?

Extremely small market capitalization ($0.00B) and very low P/E ratio (0.29) may indicate limited public market interest or liquidity.

  • Limited public disclosure as an OTC Other stock, potentially hindering investor confidence and transparency.
  • Small team of 3 employees may limit capacity for extensive due diligence or portfolio management across numerous investments.
  • Reliance on successful exits from a potentially concentrated portfolio for generating significant returns.
  • Unusual and extreme negative Beta (-130.35) suggests high volatility or unique market dynamics that could be difficult to interpret or manage.

What Are the Key Risks for CHAM?

Extreme illiquidity and lack of public disclosure, stemming from its 'OTC Other' status and 'Unknown' disclosure, pose significant challenges for investors seeking to buy or sell shares.

  • The small team of three employees may face capacity constraints in managing a diverse portfolio and conducting extensive due diligence for new investments.
  • Reliance on the performance and successful exits of a potentially concentrated portfolio of private investments, which carry inherent risks of failure or underperformance.
  • Economic downturns or adverse market conditions in its target sectors (technology, life sciences, medical, consumer) could negatively impact the valuation and exit opportunities for portfolio companies.
  • The highly unusual and extreme negative Beta (-130.35) could indicate unpredictable market behavior or a statistical anomaly that does not reliably reflect the firm's underlying investment risks.

What Threats Does CHAM Face?

  • Intense competition from larger, more established private equity and venture capital firms.
  • Economic downturns or sector-specific slowdowns could negatively impact portfolio company performance and exit opportunities.
  • Regulatory changes affecting private equity or venture capital investments could increase compliance costs.
  • Difficulty in attracting new capital or limited partners due to its OTC trading status and limited public information.
  • Failure of key portfolio investments could significantly impact overall firm performance and profitability.

What Are CHAM's Competitive Advantages?

  • Specialized investment criteria focused on specific revenue and EBITDA ranges, allowing for targeted deal sourcing.
  • Expertise in niche sectors: technology, life sciences, medical, and consumer, providing deep industry insight.
  • Established network for deal flow and exit opportunities within the U.S. private market.
  • Flexible investment strategies including early-stage, growth, acquisitions, and recapitalizations, catering to diverse company needs.
  • Long-term investment horizon (3-7 years) fostering patient capital and value creation.

What Does CHAM Do?

Champion Investments, Inc. is a private equity and venture capital firm headquartered in Houston, Texas, with a specialized focus on a diverse range of investment stages and transaction types. The firm's core expertise lies in identifying and nurturing early-stage, emerging, and small to middle-market companies, alongside micro investments and high-growth stage enterprises. Beyond initial growth capital, Champion Investments, Inc. also engages in strategic acquisitions, management buyouts, and recapitalizations, offering comprehensive financial solutions across a company's lifecycle. The firm maintains a strong preference for investing within the United States, channeling its capital into key innovation-driven sectors. Specifically, Champion Investments, Inc. targets opportunities within technology, life sciences, medical, and consumer industries, reflecting a strategic alignment with high-growth potential and evolving market demands. Investment criteria are clearly defined, with the firm typically seeking companies that generate revenues under $25 million, or more precisely, between $2 million and $25 million. Furthermore, target companies are expected to exhibit an EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) within the range of 10% to 30%. This disciplined approach allows the firm to focus on businesses with established, albeit early-to-mid-stage, operational performance and clear growth trajectories. Champion Investments, Inc. evaluates potential returns on investment over a strategic timeframe of three to seven years, indicating a patient capital approach designed to foster long-term value creation for its portfolio companies. With a lean operational structure, the firm manages its investment activities from its Houston base, contributing to the broader financial services landscape through its specialized private equity and venture capital offerings.

What Products and Services Does CHAM Offer?

  • Invests in early-stage companies, providing crucial seed and growth capital.
  • Specializes in emerging and small to middle-market companies, supporting their expansion and development.
  • Engages in micro investments, targeting smaller ventures with high growth potential.
  • Focuses on high-growth stage companies, helping them scale operations and market reach.
  • Participates in acquisitions and buyouts, facilitating ownership changes and strategic consolidations.
  • Undertakes recapitalizations, restructuring a company's capital structure for various strategic objectives.
  • Prefers investments in the United States, concentrating on domestic market opportunities.
  • Targets specific sectors including technology, life sciences, medical, and consumer industries.

How Does CHAM Make Money?

  • Generates returns through capital appreciation from successful exits (e.g., IPOs, acquisitions) of its portfolio companies.
  • Earns management fees and carried interest from the funds it manages, based on assets under management and investment performance.
  • Invests in companies meeting specific financial criteria: revenues under $25 million (typically $2-$25 million) and EBITDA between 10-30%.
  • Aims for a three to seven-year investment timeframe to realize returns on its capital deployments.
  • Focuses on value creation through strategic guidance, operational improvements, and financial restructuring of portfolio companies.

What Industry Does CHAM Operate In?

Champion Investments, Inc. operates within the highly competitive and dynamic Asset Management industry, specifically focusing on the private equity and venture capital segments. This sector is characterized by its role in providing capital to private companies, fostering innovation, and driving economic growth, particularly in early-stage and high-growth markets. The broader industry has seen significant capital inflows, with investors increasingly seeking alternative assets for diversification and higher returns. Champion Investments, Inc. distinguishes itself by targeting specific niches within technology, life sciences, medical, and consumer sectors, and by adhering to strict investment criteria based on company revenues (typically $2-$25 million) and EBITDA (10-30%). This focused approach allows the firm to compete by specializing in segments often overlooked by larger, more generalized funds. The competitive landscape includes a vast array of venture capital firms, private equity funds, and institutional investors, all vying for promising investment opportunities. Champion Investments, Inc.'s strategy of a three to seven-year investment horizon aligns with industry standards for value creation in private markets.

Who Are CHAM's Key Customers?

  • Early-stage startups seeking seed or Series A funding for product development and market entry.
  • Emerging companies requiring growth capital to scale operations, expand market share, or develop new products.
  • Small to middle-market businesses looking for capital for acquisitions, buyouts, or recapitalizations.
  • Entrepreneurs and management teams seeking strategic partners with industry expertise and financial resources.
  • Investors (limited partners) seeking exposure to private markets and high-growth potential through a specialized fund manager.
Model self-rating on this text: 68% (not a measure of the evidence) Updated: Jun 15, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage

Company Profile

Champion Investments, Inc. operates in the Asset Management industry within the Financial Services sector. It is headquartered in Houston, US. The company is led by CEO Kerri G. Schomette. CHAM has traded publicly since 2007.

ROE 10%

Key Financial Metrics

Return on equity for Champion Investments, Inc. stands at 10.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 10.2%, showing how much profit it generates from its asset base. CHAM trades at a trailing price-to-earnings ratio of 0.29, below the Financial Services sector average of ~17.20x.

CHAM Financials

Fundamental Snapshot

P/E (TTM)
0.29
Return on Equity (TTM)
+10.2%

Based on FMP financials and quantitative analysis

CHAM Latest News

CHAM Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CHAM.

Price Targets

Wall Street price target analysis for CHAM.

CHAM MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CHAM; grades run from A+ (80-100) to F (below 30).

Leadership: Kerri G. Schomette

Managing Director

Kerri G. Schomette serves as the Managing Director of Champion Investments, Inc., overseeing the firm's strategic direction and investment activities. With a focus on private equity and venture capital, Ms. Schomette leads a lean team, guiding the firm's specialization in early-stage, emerging, and small to middle-market companies. Her responsibilities encompass identifying investment opportunities, conducting due diligence, and managing portfolio companies within the technology, life sciences, medical, and consumer sectors. Ms. Schomette's leadership is central to the firm's approach of targeting U.S.-based companies that meet specific revenue and EBITDA criteria, aiming for long-term value creation.

Track Record: Under Kerri G. Schomette's leadership, Champion Investments, Inc. has maintained its specialized focus on high-growth potential companies within its target sectors. Her strategic decisions have guided the firm's investment in companies with revenues between $2 million and $25 million and EBITDA of 10-30%, adhering to a disciplined investment philosophy. The firm's reported high profit and gross margins reflect the successful execution of its investment strategies and potentially profitable exits or valuations of its private holdings under her tenure. Ms. Schomette's management of the firm's three employees underscores an efficient operational model focused on specialized investment management.

CHAM OTC Market Information

Champion Investments, Inc. trades on the 'OTC Other' tier of the OTC Markets Group. This tier is typically for companies that do not meet the financial or disclosure standards of OTCQX or OTCQB, or choose not to provide information to OTC Markets. Companies in this tier are not required to provide current public information to OTC Markets, making them the most speculative and least transparent of all OTC-traded securities. This contrasts sharply with exchanges like NYSE or NASDAQ, which have stringent listing requirements for financial reporting, corporate governance, and minimum share prices, ensuring a higher level of transparency and investor protection.

  • OTC Tier: OTC Other
Liquidity: Given its 'OTC Other' tier classification, 'Unknown' disclosure status, and reported market capitalization of $0.00B, Champion Investments, Inc. likely experiences extremely low liquidity. Trading volume is expected to be minimal, and the bid-ask spread could be very wide, making it difficult for investors to buy or sell shares at a desired price. This illiquidity implies significant challenges in entering or exiting positions, potentially leading to substantial price volatility on limited trading activity.
OTC Risk Factors:
  • **Lack of Transparency:** Unknown disclosure status means investors have virtually no access to current financial or operational information, making informed investment decisions extremely difficult.
  • **Extreme Illiquidity:** A market capitalization of $0.00B and 'OTC Other' status typically indicate very low trading volume and wide bid-ask spreads, making it hard to buy or sell shares.
  • **Regulatory Oversight:** OTC Other companies have minimal regulatory oversight compared to exchange-listed stocks, increasing the risk of fraud or mismanagement.
  • **Price Volatility:** Low trading volume and limited information can lead to extreme price fluctuations based on minimal activity or news.
  • **Limited Investor Protection:** Investors in OTC Other securities have fewer protections and remedies compared to those investing in exchange-listed companies.
Due Diligence Checklist:
  • Verify any available corporate filings with state regulators, even if not publicly disclosed via OTC Markets.
  • Attempt to contact company management directly for any available financial statements or business updates.
  • Research any news articles, press releases, or legal filings related to the company, however scarce.
  • Understand the specific risks associated with 'OTC Other' tier, including potential for fraud and lack of liquidity.
  • Assess the company's business model and investment strategy based on any historical information, recognizing its age.
  • Consider the extremely low market capitalization and P/E ratio in the context of its illiquidity and disclosure status.
  • Evaluate the extreme negative Beta (-130.35) as a potential statistical anomaly rather than a reliable market correlation.
Legitimacy Signals:
  • The company is officially incorporated and headquartered in Houston, Texas, indicating a physical presence.
  • It has a named CEO, Kerri G. Schomette, providing a point of contact for leadership.
  • The firm has a clearly defined business description and investment strategy, including target sectors and financial criteria.
  • It operates within a recognized industry (Financial Services, Asset Management), albeit with limited public information.
  • The firm specifies an investment horizon (three to seven years), suggesting a structured approach to its private investments.

Champion Investments, Inc. Financials Stock: Key Questions Answered

What are the main risks for CHAM, particularly as an OTC-traded entity?

Investing in CHAM carries significant risks, largely due to its status as an 'OTC Other' stock with an 'Unknown' disclosure level.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • The market capitalization of $0.00B and the extreme negative Beta of -130.35 are highly unusual and have been stated factually without speculative interpretation beyond their direct implications for liquidity and market correlation.
  • The 'Unknown' disclosure status for an OTC Other stock significantly limits the depth of analysis possible for financial performance and operational details.
  • CEO background and track record are inferred from the limited provided data (managing 3 employees) and the nature of the firm's business model.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis